Email updates

Keep up to date with the latest news and content from Arthritis Research & Therapy and BioMed Central.

This article is part of the supplement: B cell targeted therapy: a new approach to the treatment of rheumatoid arthritis

Highly Accessed Review

B cell non-Hodgkin's lymphoma: rituximab safety experience

Ann Mohrbacher

Arthritis Research & Therapy 2005, 7(Suppl 3):S19-S25  doi:10.1186/ar1739

Article Metrics

7807
Total accesses

Article metric FAQ

Accesses  

  • Last 30 days: 65 accesses
  • Last 365 days: 494 accesses
  • All time: 7807 accesses

These numbers are accesses on BioMed Central websites only, and an underestimate of total usage. More information